Cargando…
Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study
BACKGROUND: Cariprazine, a novel antipsychotic drug, is a partial agonist of dopamine D2/D3 receptors with preferential binding to the D3 receptor. There has been an increasing interest in cariprazine augmentation to clozapine; however, the evidence thus far has been only limited to case reports and...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685211/ https://www.ncbi.nlm.nih.gov/pubmed/36439679 http://dx.doi.org/10.1177/20451253221132087 |